Difficult Insulinoma

Gill G.V. , Rauf O. , Macfarlane IA. Diazoxide treatment for insulinoma: a national UK survey. Postgrad Med J 1997; 73: 640–1

Barrons RW. Octreotide in hyperinsulinism. Ann Pharmacother 1997; 31: 239–41

Gama R. , Marks V. , Wright J. , Teale JD. Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon. Clin Endocrinol 1995; 43: 117–20

Hoff A.O. , Vassilopoulou-Sellin R. The role of glucagon administration in the diagnosis and treatment of patients with tumour hypoglycemia. Cancer 1998; 82: 1585–92

Samaan N.A. , Pham F.K. , Sellin R.V. , Fernandez J.F. , Benjamin RS. Successful treatment of hypoglycemia using glucagon in a patient with extrapancreatic tumour. Ann Intern Med 1990; 113: 404–6